C. Frank Bennett
C. Frank Bennett is an American scientist known for his contributions to the field of genetics and neuroscience. He is a co-founder and the Senior Vice President of Research at Ionis Pharmaceuticals, a biotechnology company specializing in the development of antisense oligonucleotide therapies.
Early Life and Education[edit | edit source]
Bennett received his B.S. degree in Pharmacy from the University of New Mexico. He then went on to earn his Ph.D. in Pharmacology from the University of Pennsylvania.
Career[edit | edit source]
Bennett began his career in the pharmaceutical industry, focusing on the development of novel therapeutic approaches. In 1989, he co-founded Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals), where he has played a pivotal role in advancing the company's research and development efforts.
Contributions to Science[edit | edit source]
Bennett is widely recognized for his work in the development of antisense oligonucleotides, a class of drugs designed to target and regulate the expression of specific genes. His research has led to the development of several FDA-approved therapies, including Spinraza (nusinersen), the first treatment for spinal muscular atrophy (SMA).
Antisense Oligonucleotides[edit | edit source]
Antisense oligonucleotides are short, synthetic strands of nucleic acids that can bind to RNA molecules, modulating their function. This technology has been applied to treat a variety of genetic disorders, including Huntington's disease, amyotrophic lateral sclerosis (ALS), and Duchenne muscular dystrophy.
Awards and Honors[edit | edit source]
Bennett has received numerous awards for his contributions to medical science, including the Oligonucleotide Therapeutics Society Lifetime Achievement Award and the American Chemical Society's Heroes of Chemistry Award.
Personal Life[edit | edit source]
Bennett resides in California and continues to be actively involved in research and development at Ionis Pharmaceuticals.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Template:Ionis Pharmaceuticals
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD